[Retracted] miR-206 Inhibits Laryngeal Carcinoma Cell Multiplication, Migration, and Invasion

Table 1

Correlation of serum miR-206 expression with clinical characteristics of patients.

Clinicopathological parameters	n	miR-206
		High expression (n = 34)	Low expression (n = 34)	t/F
Gender				1.308	0.253
Male	52	24 (70.59)	28 (82.35)
Female	16	10 (29.41)	16 (17.65)
Age (years)				2.147	0.143
<60	38	22 (64.71)	16 (47.06)
≥60	30	12 (35.29)	18 (52.94)
TNM staging				7.275	0.007
I-II	29	20 (58.82)	9 (26.47)
III-IV	39	14 (41.18)	25 (73.53)
Differentiation degree				1.472	0.225
High/moderate differentiation	33	19 (55.88)	14 (41.18)
Low differentiation	35	15 (44.12)	20 (58.82)
Tumor diameter (cm)				0.541	0.462
>3	39	21 (61.76)	18 (52.94)
≤3	29	13 (38.24)	16 (47.06)
Tumor location				0.569	0.451
Supraglottic type	25	14 (41.18)	11 (32.35)
Glottic type	43	20 (58.82)	23 (67.65)
History of smoking				0.971	0.324
No	28	16 (47.06)	12 (35.29)
Yes	40	18 (52.94)	22 (64.71)